Profile

Purdue Pharma Canada

Profile for Purdue Pharma Canada. Every fact below is a verbatim quote from a real document we have stored. ↩ See the full Record

Relationships
controls OxyContin
other Pappin, Bavli, and Herder
other Pappin, Bavli, and Herder
other Pappin, Bavli, and Herder
other Connecticut
funded University of Toronto
member_of Purdue Pharma Canada
other OxyContin
funded University of Toronto
funded Brian Goldman
funded University of Toronto
other reformulation of OxyContin
other Knoa Pharma
other Canada
Established facts
  • Payments like this are a rounding error for big drug companies · source
  • Canada has no whistleblower-style False Claims Act equivalent ↗ · source
  • National opioid dispensing dropped 14.9% (Feb 2012 – Apr 2016) ↗ · source
  • oxycodone dispensing nationally dropped 46.4% (Gomes et al., 2017) · source
  • Fentanyl rose from 25.8% of opioid-related deaths in Ontario in 2012 to nearly 90% by 2021 · source
  • The agency relied on two internal drug-report searches in May and July 2001 that found no adverse drug reports involving OxyContin. ↗ · source
  • The 2006 revision merely added the word "usually" to the misleading claim — i.e., "Drug abuse is usually not a problem…" ↗ · source
  • Purdue Canada distributed a pain management book to doctors and health professions students at the University of Toronto between 2004 and 2010 · source
Drawn from 5 source documents in the Library. Every attribute and relationship above traces back to a verbatim quote.